Short-term medication cost savings for treating hypertension and diabetes after gastric bypass

Surgery for Obesity and Related Diseases

Volumn 8, Issue 3, 2012, Pages 269-274

  Ghiassi, Saber ^a,b   Morton, John ^a   Bellatorre, Nina ^b   Eisenberg, Dan ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Diabetes; Gastric bypass; Healthcare cost; Hypertension; Medication cost

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; MEGLITINIDE; SULFONYLUREA DERIVATIVE;

ADULT; BARIATRIC SURGERY; COST CONTROL; DIABETES MELLITUS; DRUG COST; FEMALE; HEALTH CARE SYSTEM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; REVIEW; ROUX Y ANASTOMOSIS; STOMACH BYPASS;

EID: 84861186900     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2011.05.009     Document Type: Article

References (34)

1. L. Salem, C.C. Jensen, D.R. Flum Are bariatric surgical outcomes worth their cost? A systematic review J Am Coll Surg 200 2005 270 278
2. S. Gallagher, M. Banasiak, J. Gonzalvo The impact of bariatric surgery on the Veterans Administration healthcare system: a cost analysis Obes Surg 13 2003 245 248
3. K.M. Flegal, M.D. Carroll, C.L. Ogden, L.R. Curtin Prevalence and trends in obesity among US adults, 1999-2008 JAMA 303 2010 235 241
4. K.A. Powers, S.T. Rehrig, D.B. Jones Financial impact of obesity and bariatric surgery Med Clin North Am 91 2007 321 338
5. E.A. Finkelstein, J.G. Trogdon, J.W. Cohen, W. Dietz Annual medical spending attributable to obesity: payer- and service-specific estimates Health Aff 28 2009 822 831
6. K. Nabro, G. Agren, E. Jonsson, I. Näslund, L. Sjöström, M. Peltonen Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS Intervention Study Arch Intern Med 162 2002 2061 2069
7. H. Buchwald, Y. Avidor, E. Braunwald Bariatric surgery: a systematic review and meta-analysis JAMA 292 2004 1724 1737
8. H.J. Sugerman, L.G. Wolfe, D.A. Sica, J.N. Clore Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss Ann Surg 237 2003 751 758
9. W.J. Pories, M.S. Swanson, K.G. MacDonald Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus Ann Surg 222 1995 339 350
10. K.G. MacDonald Jr, S.D. Long, M.S. Swanson The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus J Gastrointest Surg 1 1997 213 220
11. A.R. Ahmed, G. Rickards, D. Coniglio Laparoscopic Roux-en-Y gastric bypass and its early effect on blood pressure Obes Surg 19 2009 845 849
12. J.L. Carson, M.E. Ruddy, A.E. Duff, N.J. Holmes, R.P. Cody, R.E. Brolin The effect of gastric bypass surgery on hypertension in morbidly obese patients Arch Intern Med 154 1994 193 200
13. M.W. Hinojosa, J.E. Varela, B.R. Smith, F. Che, N.T. Nguyen Resolution of systemic hypertension after laparoscopic gastric bypass J Gastrointest Surg 13 2009 793 797
14. C.D. Sjöström, L. Lissner, H. Wedel, L. Sjöström Reduction in incidence of diabetes, hypertension, and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study Obes Res 7 1999 477 484
15. D. Thompson, J. Edelsberg, G. Colditz, A. Bird, G. Oster Lifetime health and economic consequences of obesity Arch Intern Med 159 1999 2177 2183
16. B.M. Craig, D.S. Tseng Cost-effectiveness of gastric bypass for severe obesity Am J Med 113 2002 491 498
17. A.J. Clegg, J. Colquitt, M.K. Sidhu, P. Royle, E. Loveman, A. Walker The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation Health Technol Assess 6 2002 1 153
18. L. Salem, A. Devlin, S.D. Sullivan, D.R. Flum Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions Surg Obes Relat Dis 4 2008 26 32
19. P.Y. Cremieux, H. Buchwald, S.A. Shikora, A. Ghosh, H.E. Yang, M. Buessing A study on the economic impact of bariatric surgery Am J Manag Care 14 2008 589 596
20. E.H. Livingston Hospital costs associated with bariatric procedures in the United States Am J Surg 190 2005 816 820
21. S. Ikramuddin, C.D. Klingman, T. Swan, M.E. Minshall Cost-effectiveness of Roux-en-Y gastric bypass in type 2 diabetes patients Am J Manag Care 15 2009 607 615
22. M. Heron, D.L. Hoyert, S.L. Murphy, J. Xu, K.D. Kochanek, B. Tejada-Vera Deaths: final data for 2006 Natl Vital Stat Rep 57 2009 1 135
23. A. Peeters, J.J. Barendregt, F. Willekens, J.P. Mackenbach, A.A. Mamun, L. Bonneux Obesity in adulthood and its consequences for life expectancy: a life-table analysis Ann Intern Med 138 2003 24 32
24. D.R. Flum, E.P. Dellinger Impact of gastric bypass operation on survival: a population-based analysis J Am Coll Surg 199 2004 543 551
25. P.Y. Cremieux, S. Ledoux, C. Clerici, F. Cremieux, M. Buessing The impact of bariatric surgery on comorbidities and medication use among obese patients Obes Surg 20 2010 861 870
26. G. Segato, L. Busetto, M. De Luca Weight loss and changes in use of antidiabetic medication in obese type 2 diabetics after laparoscopic gastric banding Surg Obes Relat Dis 6 2010 132 137
27. L.L. Snow, L.S. Weinstein, J.K. Hannon The effect of Roux-en-Y gastric bypass on prescription drug costs Obes Surg 14 2004 1031 1035
28. 2 Obesity (Silver Spring) 19 2011 581 587
29. N.T. Nguyen, J.E. Varela, A. Sabio, J. Naim, M. Stamos, S.E. Wilson Reduction in prescription medication costs after laparoscopic gastric bypass Am Surg 72 2006 853 856
30. D. Eisenberg, R.L. Bell The impact of bariatric surgery on severely obese patients with diabetes Diabetes Spectr 16 2003 240 245
31. D.M. Herron, W. Tong Role of surgery in management of type II diabetes Mt Sinai J Med 76 2009 281 293
32. J.S. Monk Jr, N. Dia Nagib, W. Stehr Pharmaceutical savings after gastric bypass surgery Obes Surg 14 2004 13 15
33. M.L. Maciejewski, E.H. Livingston, L.C. Kahwati, W.G. Henderson, A.L. Kavee, D.E. Arterburn Discontinuation of diabetes and lipid-lowering medications after bariatric surgery at Veterans Affairs medical centers Surg Obes Relat Dis 6 2010 601 607
34. K.M. Nelson The burden of obesity among a national probability sample of veterans J Gen Intern Med 21 2006 915 919